Utilizing wearable sensors for continuous and highly-sensitive monitoring of reactions to the BNT162b2 mRNA COVID-19 vaccine

Gepner et al. undertake a prospective observational study using a chest-patch sensor to monitor cardiovascular and hemodynamic vital signs following the BNT162b2 COVID-19 (Pfizer BioNTech) vaccine. Continuous and significant changes occurred in the vital signs, including in participants who did not...

Full description

Bibliographic Details
Main Authors: Yftach Gepner, Merav Mofaz, Shay Oved, Matan Yechezkel, Keren Constantini, Nir Goldstein, Arik Eisenkraft, Erez Shmueli, Dan Yamin
Format: Article
Language:English
Published: Nature Portfolio 2022-03-01
Series:Communications Medicine
Online Access:https://doi.org/10.1038/s43856-022-00090-y